Aclaris TherapeuticsACRS
那斯達克 · USD
1.93
+0.09
(+4.62%)
收盤 08/30 03:59 (UTC+8)
盤後
1.93
+0.01
(+0.26%)
08/30 03:59 (UTC+8)
Aclaris TherapeuticsACRS
1.93
+0.09
(+4.62%)
財務數據
損益表
- 0.03
- 0.02
- 0.09
- 0.18
- 0.02
- 0.03
- 0.04
- 0.09
- 0.01
- 0.02
- -67.39
- -26.07
- 396.63
- 89.29
- -86.35
- 15.30
- 57.18
- 111.94
- -84.20
- 22.13
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 1,777 | 1,455 | 9,211 | 4,346 | 2,765 | 2,398 | 17,570 | 9,282 | 1,869 | 2,528 |
營業成本 | 1,850 | 506 | 705 | 654 | 624 | 809 | 725 | 848 | 1,042 | 808 |
營業毛利 | -73 | 949 | 8,506 | 3,692 | 2,141 | 1,589 | 16,845 | 8,434 | 827 | 1,720 |
營業費用 | 16,835 | - | - | - | - | - | - | 40,011 | 32,642 | 31,638 |
研發費用 | 11,449 | 11,584 | 9,026 | 5,956 | 8,759 | 9,845 | 26,646 | 23,876 | 25,275 | 22,587 |
推銷及管理費用 | 5,386 | 7,449 | 12,250 | 8,207 | 6,237 | 10,675 | -12,383 | 16,135 | 7,367 | 9,051 |
非經常性項目費用 | - | - | 86,905 | - | - | - | 6,629 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -16,908 | -18,084 | -99,675 | -10,471 | -12,855 | -18,931 | -4,047 | -31,577 | -31,815 | -29,918 |
其他收入及費用 | - | 2,999 | 3,123 | 2,885 | 1,869 | 1,990 | 2,189 | 2,316 | 2,246 | 1,758 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -15,429 | -15,085 | -96,552 | -7,586 | -10,986 | -16,941 | -1,858 | -29,261 | -29,569 | -28,160 |
所得稅 | - | - | - | - | - | - | -367 | - | - | - |
稅後純益 | -15,429 | -15,085 | -96,552 | -7,586 | -10,986 | -16,941 | -1,491 | -29,261 | -29,569 | -28,160 |
基本每股稅後盈餘(元) | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | - | -0.41 | -0.42 | -0.42 |
稀釋每股稅後盈餘(元) | -0.13 | -0.12 | -1.21 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.42 |
基本平均股數(千股) | 122580.00 | 122390.00 | 95305.00 | 71381.00 | 71291.00 | 71074.00 | - | 70807.00 | 70633.00 | 66872.00 |
稀釋平均股數(千股) | 122580.00 | 122390.00 | 95305.00 | 71381.00 | 71291.00 | 71074.00 | - | 70807.00 | 70633.00 | 66872.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | - | -0.41 | -0.42 | -0.42 |
還原稀釋每股稅後盈餘(元) | -0.13 | -0.12 | -1.21 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.42 |
還原基本平均股數(千股) | 122,580 | 122,390 | 95,305 | 71,381 | 71,291 | 71,074 | - | 70,807 | 70,633 | 66,872 |
還原稀釋平均股數(千股) | 122,580 | 122,390 | 95,305 | 71,381 | 71,291 | 71,074 | - | 70,807 | 70,633 | 66,872 |
EBITDA(千元) | -15,315 | -14,957 | -96,409 | -7,407 | -10,744 | -16,698 | -1,630 | -29,042 | -29,351 | -27,962 |